← 研究资料库
AO RESEARCH · 2026.10.03
行业研究与来源档案
按主题阅读统计、财务、赛事、参与调查、公共采购及场馆服务资料;原文时点、单位、地区与仍需对照确认的范围逐条保留。
资料条数不代表新产品、新法人或正式指数样本。来源中的发布、计分和图片使用批准状态保持原样。
研究简报与总报告
游泳计时资料中的设备与系统边界中文原文及英文摘要研究原文与范围 →路跑与马拉松同类群:2024—2025公开来源边界中文原文及英文摘要研究原文与范围 →公共来源可比组研究:2026年10月3日中文原文及英文摘要研究原文与范围 →三家装备发行人:2024—2025披露比较中文原文及英文摘要研究原文与范围 →2025三场全程马拉松:事件、主体角色与项目地点中文原文及英文摘要研究原文与范围 →体育产业来源研究:英文摘要英文摘要(非中文全文译文)研究原文与范围 →全国体育产业与体育场地时间序列:英文摘要英文摘要(非中文全文译文)研究原文与范围 →2019—2024全国体育场地公告:英文摘要英文摘要(非中文全文译文)研究原文与范围 →全国体育产业与体育场地官方年度序列中文原文研究原文与范围 →公开体育设施采购:修订样本与审计限制中文原文研究原文与范围 →限上体育娱乐零售:年度片段与修订边界中文原文及英文摘要研究原文与范围 →从开放计划到实际服务产出中文原文研究原文与范围 →从开放计划到实际服务产出:英文摘要英文摘要(非中文全文译文)研究原文与范围 →
阅读行业指数研究总报告 →条件化规格研究:逐一选择身份
OMEGA Quantum Aquatics Primary 3480.911 游泳计时器OMEGA OCP5 190/90 游泳触板,2924.005VIP MATCH chairVIP Match Player bench比赛双杠跳马台平衡木
7个异构研究身份、70条来源观察;分别展示,不计新增产品或70个统一标量参数。
主题关联用于查阅,不代表对象分类已接受。记录保留来源范围、单位、时间与冲突;不计新增产品或法人。
场馆监测采购公告与履约范围1 条可读研究记录体育数字平台的来源能力声明29 条可读研究记录历史体质监测服务公告3 条可读研究记录具名体育营地与日期范围3 条可读研究记录租赁与服务范围资料7 条可读研究记录体育文旅项目与历史名录78 条可读研究记录机构治理与公共体育项目资料4 条可读研究记录场馆规划设计项目来源5 条可读研究记录场馆历史开放公告与条件8 条可读研究记录发行人财务与业务范围150 条可读研究记录路跑届次与分析计算55 条可读研究记录体育参与调查与比较边界75 条可读研究记录零售原值与缺失年份20 条可读研究记录赛事届次、角色与规模69 条可读研究记录地址角色与区域研究26 条可读研究记录认证目录与零售型号边界21 条可读研究记录 · 2 条暂缓公共采购金额与阶段14 条可读研究记录 · 4 条暂缓场馆服务产出与冲突73 条可读研究记录 · 2 条暂缓Flame 5页面规格与条件13 条可读研究记录 · 14 条暂缓路跑鞋发布页面字段38 条可读研究记录 · 2 条暂缓照明资料与保修范围7 条可读研究记录VIP座椅系列与配置16 条可读研究记录Spirit地域用途与售后条件0 条可读研究记录 · 7 条暂缓特步年报中的型号说明1 条可读研究记录公司历史披露与角色10 条可读研究记录
三家公开装备发行人样本
100 条资料 · 1 / 5
来源版本与完整性
SHA-256 fe4e47549917b5cb1d345e31653743d2adc0d4134c5ff1e1828c8097d6f65cb5
保留原始来源版本,供研究复核。
来源记录 1
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- revenue_total
- 原指标名称
- 营业收入
- 原报告数词
- 1,417,094,638.60
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 1417094638.60
- 换算单位
- CNY
- display value source units
- 1417094638.60
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 6
- 印刷页码
- 6
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2024_revised_p006.png
- additional evidence
- PDF页码
- 6
- 印刷页码
- 6
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 2
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_expense
- 原指标名称
- 研发费用
- 原报告数词
- 43,673,742.07
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 43673742.07
- 换算单位
- CNY
- display value source units
- 43673742.07
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 24
- 印刷页码
- 24
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF页码
- 24
- 印刷页码
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 3
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_input_total
- 原指标名称
- 研发投入合计
- 原报告数词
- 43,673,742.07
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 43673742.07
- 换算单位
- CNY
- display value source units
- 43673742.07
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 24
- 印刷页码
- 24
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF页码
- 24
- 印刷页码
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Total R&D input as disclosed, not substituted from expense
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 4
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_input_capitalized
- 原指标名称
- 本期资本化研发投入
- 原报告数词
- 0.00
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 0.00
- 换算单位
- CNY
- display value source units
- 0.00
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 24
- 印刷页码
- 24
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF页码
- 24
- 印刷页码
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 5
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_intensity_reported
- 原指标名称
- 研发投入总额占营业收入比例(%)
- 原报告数词
- 3.08
- 原报告单位
- %
- normalization factor
- 0.01
- 换算展示值
- 0.0308
- 换算单位
- ratio
- display value source units
- 3.08
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 24
- 印刷页码
- 24
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:10:45.592311+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2024_revised_p024.png
- additional evidence
- PDF页码
- 24
- 印刷页码
- 24
- role
- superseded original table amount agreement for curated scope only
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Issuer rounded percentage; derived ratio stored separately
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 6
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- revenue_total
- 原指标名称
- 营业收入
- 原报告数词
- 1,566,259,241.04
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 1566259241.04
- 换算单位
- CNY
- display value source units
- 1566259241.04
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 7
- 印刷页码
- 7
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2025_p007.png
- additional evidence
- — 未披露
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 7
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_expense
- 原指标名称
- 研发费用
- 原报告数词
- 53,588,214.84
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 53588214.84
- 换算单位
- CNY
- display value source units
- 53588214.84
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 25
- 印刷页码
- 25
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2025_p025.png
- additional evidence
- — 未披露
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 8
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_input_total
- 原指标名称
- 研发投入合计
- 原报告数词
- 53,588,214.84
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 53588214.84
- 换算单位
- CNY
- display value source units
- 53588214.84
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 26
- 印刷页码
- 26
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — 未披露
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Total R&D input as disclosed, not substituted from expense
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 9
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_input_capitalized
- 原指标名称
- 本期资本化研发投入
- 原报告数词
- 0.00
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 0.00
- 换算单位
- CNY
- display value source units
- 0.00
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 26
- 印刷页码
- 26
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — 未披露
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 10
- issuer legal name
- 舒华体育股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_intensity_reported
- 原指标名称
- 研发投入总额占营业收入比例(%)
- 原报告数词
- 3.42
- 原报告单位
- %
- normalization factor
- 0.01
- 换算展示值
- 0.0342
- 换算单位
- ratio
- display value source units
- 3.42
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 26
- 印刷页码
- 26
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:08:10.246189+00:00
- access window utc
- — 未披露
- evidence capture
- captures/shuhua_2025_p026.png
- additional evidence
- — 未披露
- restatement scope
- 2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
- continuing operations scope
- Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
- notes
- Issuer rounded percentage; derived ratio stored separately
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 11
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- revenue_total
- 原指标名称
- 营业收入
- 原报告数词
- 1,213,857,643.97
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 1213857643.97
- 换算单位
- CNY
- display value source units
- 1213857643.97
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 8
- 印刷页码
- 8
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — 未披露
- evidence capture
- captures/impulse_2024_p008.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 12
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_expense
- 原指标名称
- 研发费用
- 原报告数词
- 52,552,467.25
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 52552467.25
- 换算单位
- CNY
- display value source units
- 52552467.25
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 30
- 印刷页码
- 30
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — 未披露
- evidence capture
- captures/impulse_2024_p030.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 13
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_input_total
- 原指标名称
- 研发投入金额(元)
- 原报告数词
- 52,552,467.25
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 52552467.25
- 换算单位
- CNY
- display value source units
- 52552467.25
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 32
- 印刷页码
- 32
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — 未披露
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Total R&D input as disclosed, not substituted from expense
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 14
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_input_capitalized
- 原指标名称
- 研发投入资本化的金额(元)
- 原报告数词
- 0.00
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 0.00
- 换算单位
- CNY
- display value source units
- 0.00
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 32
- 印刷页码
- 32
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — 未披露
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 15
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2024-01-01
- 期间结束
- 2024-12-31
- 期间类型
- fiscal_year
- 年份
- 2024
- 指标
- rd_intensity_reported
- 原指标名称
- 研发投入占营业收入比例
- 原报告数词
- 4.33%
- 原报告单位
- %
- normalization factor
- 0.01
- 换算展示值
- 0.0433
- 换算单位
- ratio
- display value source units
- 4.33
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 32
- 印刷页码
- 32
- 原始链接
- 查看原始出处 ↗
- access utc
- 2026-10-03T11:09:47.328225+00:00
- access window utc
- — 未披露
- evidence capture
- captures/impulse_2024_p032.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Issuer rounded percentage; derived ratio stored separately
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 16
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- revenue_total
- 原指标名称
- 营业收入
- 原报告数词
- 1,175,906,664.10
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 1175906664.10
- 换算单位
- CNY
- display value source units
- 1175906664.10
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 8
- 印刷页码
- 8
- 原始链接
- 查看原始出处 ↗
- access utc
- — 未披露
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p008.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 17
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_expense
- 原指标名称
- 研发费用
- 原报告数词
- 51,565,452.91
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 51565452.91
- 换算单位
- CNY
- display value source units
- 51565452.91
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 28
- 印刷页码
- 28
- 原始链接
- 查看原始出处 ↗
- access utc
- — 未披露
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p028.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Income statement expense; independently distinguished from total R&D input even where amounts match
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 18
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_input_total
- 原指标名称
- 研发投入金额(元)
- 原报告数词
- 51,565,452.91
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 51565452.91
- 换算单位
- CNY
- display value source units
- 51565452.91
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 29
- 印刷页码
- 29
- 原始链接
- 查看原始出处 ↗
- access utc
- — 未披露
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Total R&D input as disclosed, not substituted from expense
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 19
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_input_capitalized
- 原指标名称
- 研发投入资本化的金额(元)
- 原报告数词
- 0.00
- 原报告单位
- 元(人民币)
- normalization factor
- 1
- 换算展示值
- 0.00
- 换算单位
- CNY
- display value source units
- 0.00
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 29
- 印刷页码
- 29
- 原始链接
- 查看原始出处 ↗
- access utc
- — 未披露
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- — 未披露
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 20
- issuer legal name
- 青岛英派斯健康科技股份有限公司
- entity scope
- consolidated legal issuer group
- 期间开始
- 2025-01-01
- 期间结束
- 2025-12-31
- 期间类型
- fiscal_year
- 年份
- 2025
- 指标
- rd_intensity_reported
- 原指标名称
- 研发投入占营业收入比例
- 原报告数词
- 4.39%
- 原报告单位
- %
- normalization factor
- 0.01
- 换算展示值
- 0.0439
- 换算单位
- ratio
- display value source units
- 4.39
- 统计范围
- consolidated issuer
- dimension
- — 未披露
- 资料状态
- canonical
- 缺失原因
- — 未披露
- PDF页码
- 29
- 印刷页码
- 29
- 原始链接
- 查看原始出处 ↗
- access utc
- — 未披露
- access window utc
- 2026-10-03T11:00:30Z
- 2026-10-03T11:03:00Z
- evidence capture
- captures/impulse_2025_p029.png
- additional evidence
- — 未披露
- restatement scope
- No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
- continuing operations scope
- Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
- notes
- Issuer rounded percentage; derived ratio stored separately
- 是否符合正式公开使用条件
- 否
- 是否符合正式计分条件
- 否
- latest Mac597 dedup status
- pending current ledger absent
- v3 exact amount candidates
- — 未披露
- v3 fact status
- new financial observation not in v3 structured claims
- v3 fact check note
- Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.

